Prosecution Insights
Last updated: May 29, 2026
Application No. 18/118,342

ENDOSCOPE SYSTEM, MANIPULATION ASSISTANCE METHOD, AND MANIPULATION ASSISTANCE PROGRAM

Non-Final OA §102§103
Filed
Mar 07, 2023
Priority
Feb 04, 2021 — provisional 63/145,580 +1 more
Examiner
SURGAN, ALEXANDRA L
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Olympus Corporation
OA Round
1 (Non-Final)
47%
Grant Probability
Moderate
1-2
OA Rounds
9m
Est. Remaining
74%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allowance Rate
234 granted / 497 resolved
-22.9% vs TC avg
Strong +27% interview lift
Without
With
+27.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
37 currently pending
Career history
538
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
91.1%
+51.1% vs TC avg
§102
4.0%
-36.0% vs TC avg
§112
3.0%
-37.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 497 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election of group I and species i in the reply filed on 10/28/2025 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Applicant asserts this reads on claims 1-5, 7, and 9. Claim 3 recites inter alia, “the processor is configured to derive both the grasp assistance information and the traction assistance information.” Grasp assistance information is not found in the elected embodiment of species i but at least in non-elected embodiment species x. Therefore claim 3 is withdrawn from consideration. Status of Claims Claims 1-20 are pending, claims 3, 6, 8, and 10-20 are withdrawn from consideration, and claims 1, 2, 4, 5, 7, and 9 are currently under consideration for patentability under 37 CFR 1.104. Foreign Priority Acknowledgment is made of applicant's claim for foreign priority under 35 U.S.C. 119(a)-(d). The certified copies have been received. Information Disclosure Statement The information disclosure statements (IDS) submitted on 03/07/2023, 01/08/2024, 01/29/2024, 09/23/2025, 10/08/2025 and 01/09/2026 have been considered by the examiner. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1,2 , 4, 7, and 9 is/are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Overmyer et al. (U.S. 2020/0188046). With respect to claim 1, Overmyer et al. teaches an endoscope system comprising: an endoscope (310) that images living tissue to be treated by at least one instrument; and a control device (102a) that includes a processor (para [0037]) configured to derive at least one of the following information: grasp assistance information on a grasping operation to grasp the living tissue by the at least one instrument, and traction assistance information on a traction operation for traction of the living tissue by the at least one instrument, based on an endoscopic image acquired by the endoscope (FIG. 7, para [0066], see also FIG. 11). With respect to claim 2, Overmyer et al. teaches a display device (206) that displays at least one of the following information: the grasp assistance information and the traction assistance information derived by the control device, in association with the endoscopic image (FIG. 7). With respect to claim 4, Overmyer et al. teaches the processor is configured to set an evaluation region in the endoscopic image of the traction operation being performed, evaluate the traction operation in the evaluation region, and output an evaluation result as the traction assistance information (wherein the entire image area is the evaluation region, FIG. 7). With respect to claim 7, Overmyer et al. teaches wherein the processor is configured to output the evaluation result as a score (FIG. 7). With respect to claim 9, Overmyer et al. teaches the processor is configured to set, as the evaluation region, a region including a fixed line where a position of the living tissue recognized from the endoscopic image remains unchanged and a position of the living tissue grasped by the at least one instrument (wherein the entire image area is the evaluation region, FIG. 7) Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 5 is/are rejected under 35 U.S.C. 103 as being unpatentable over Overmyer et al. (U.S. 2020/0188046) in view of Leiderman et al. (U.S. 2022/0104884). Overmyer et al. teaches an endoscope system as set forth above. However, Overmyer et al. does not teach the processor is configured to evaluate the traction operation from changes in feature values of the living tissue in the evaluation region. With respect to claim 5, Leiderman et al. teaches an endoscope system wherein a processor is configured to evaluate the traction operation from changes in feature values of the living tissue in the evaluation region (para [0058]). Therefore, it would have been prima facie obvious to one of ordinary skill in the art at the time of the effective filing date to modify Overmyer et al. to include iOCT means of detecting deformation of tissue in order to prevent damage to delicate structures (para [0058] of Leiderman et al.). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Alexandra Newton Surgan whose telephone number is (571)270-1618. The examiner can normally be reached Monday-Friday 8am-4pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Carey can be reached at (571) 270-7235. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALEXANDRA L NEWTON/Primary Examiner, Art Unit 3799
Read full office action

Prosecution Timeline

Mar 07, 2023
Application Filed
Feb 17, 2026
Non-Final Rejection mailed — §102, §103
May 18, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635854
MOTOR-DRIVEN ENDOSCOPE
3y 2m to grant Granted May 26, 2026
Patent 12635863
Endoscopy Device and Endoscopy System with Annular View
3y 5m to grant Granted May 26, 2026
Patent 12629284
Ear Cleaning Arrangement
1y 11m to grant Granted May 19, 2026
Patent 12616361
MEDICAL DEVICE INCLUDING A TUBE
3y 1m to grant Granted May 05, 2026
Patent 12611089
Imaging Apparatus and Method Which Utilizes Multidirectional Field of View Endoscopy
3y 7m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
47%
Grant Probability
74%
With Interview (+27.2%)
4y 0m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 497 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month